Copyright ©2010 Baishideng.
World J Stem Cells. Feb 26, 2010; 2(1): 5-12
Published online Feb 26, 2010. doi: 10.4252/wjsc.v2.i1.5
Figure 3
Figure 3 Mesenchymal stem cells as vehicle for anticancer drug. In the Figure are indicated the vectors used to engineer MSCs and the “therapeutical genes”. Target cancer cells are in parenthesis. MSCs: Mesenchymal stem cells; IL12: Interleukin-12; IFN-γ: Interferon-gamma; TRAIL: Tumor necrosis (TNF)-related apoptosis-inducing ligand.